Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)

NCT02325973 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02325973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02325973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
February 28, 2018
Enrollment
242 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

multi vessel coronary artery disease, stemi